The Broad Anti-AML Activity of the CD33/CD3 BiTE Antibody Construct, AMG 330, Is Impacted by Disease Stage and Risk.

Saved in:

Bibliographic Details
Title:	The Broad Anti-AML Activity of the CD33/CD3 BiTE Antibody Construct, AMG 330, Is Impacted by Disease Stage and Risk.
Authors:	Harrington KH; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Gudgeon CJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Laszlo GS; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Newhall KJ; Amgen, Inc., Seattle, Washington, United States of America., Sinclair AM; Amgen, Inc., Thousand Oaks, California, United States of America., Frankel SR; Amgen, Inc., Rockville, Maryland, United States of America., Kischel R; Amgen Research (Munich) GmbH, Munich, Germany., Chen G; Amgen, Inc., Seattle, Washington, United States of America., Walter RB; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Medicine, Division of Hematology, University of Washington, Seattle, Washington, United States of America; Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.
Source:	PloS one [PLoS One] 2015 Aug 25; Vol. 10 (8), pp. e0135945. Date of Electronic Publication: 2015 Aug 25 (Print Publication: 2015).
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1932-6203
DOI:	10.1371/journal.pone.0135945